Todd Schlachter, MD
Vascular & Interventional Radiology · New Haven, CTNPI 1447396296
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,250 of the $1,326 with a category attached, or 94.3%. Boston Scientific accounts for 94.3% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $1,250 and has fallen 95.5% since, to $57 in 2025. That places this record below the midpoint for vascular & interventional radiology clinicians in CT, where the typical reported total is $2,685.
Across 6 payments — averaging $221.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$35
- Penumbra, Inc.$21
- Mediview XR, Inc.$19
Across 6 payments — averaging $31,104 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Guerbet LLC$187K
What the payments were for
- Consulting fees$1,25094%
- Food & beverage$766%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $1,250 |
| Medtronic | 2 | $35 |
| Penumbra, Inc. | 1 | $21 |
| Mediview XR, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,326 in reported general payments places this provider in the 35th percentile of 50 vascular & interventional radiology providers in Connecticut.
See all vascular & interventional radiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 11 | $14 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in New Haven
- Michael TalNew Haven$5.9M
- Jean-Francois GeschwindNew Haven$337K
- John ArunyNew Haven$72K
- Sameer AhmedNew Haven$71K
- Hamid MojibianNew Haven$23K
- Alexa LeveyNew Haven$17K
- Derek BiedermanNew Haven$8K
- Fabian Laage GauppNew Haven$8K
- Tamir FriedmanNew Haven$7K
- Turgut BerkmenNew Haven$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.